Pagenax Brolucizumab 120mg/ml Injection 

Pagenax Brolucizumab 120mg/ml Injection is an advanced ophthalmic medication containing Brolucizumab, an anti-VEGF (vascular endothelial growth factor) therapy used for treating serious retinal and eye disorders. It is commonly prescribed for patients suffering from Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and other retinal vascular diseases that may lead to severe vision loss.

Brolucizumab works by blocking abnormal blood vessel growth and reducing fluid leakage inside the retina, helping stabilize or improve vision. This injection is administered directly into the eye by a qualified ophthalmologist under sterile clinical conditions.

Contact Details for Orders

• 💬 WhatsApp: +91 9730316395
• 📞 Phone: +91 9730316395
• 📧 Email: info@globmedindia.com
• 🌐 Website: globmedsindia.com

Composition and Content

• Brand Name: Pagenax Brolucizumab 120mg/ml Injection
• Generic Name: Brolucizumab
• Strength: 120 mg/ml
• Dosage Form: Injection
• Drug Category: Anti-VEGF Ophthalmic Medication
• Administration Route: Intravitreal Injection

Uses and Treatments

Pagenax Brolucizumab 120mg/ml Injection is used for:

• Wet Age-Related Macular Degeneration (AMD)
• Diabetic Macular Edema (DME)
• Retinal Vein Occlusion (RVO)
• Macular swelling and retinal vascular disorders
• Vision-threatening retinal diseases

Brolucizumab helps reduce retinal swelling and prevents abnormal blood vessel leakage that can damage eyesight.

How to Use

• Administered only by a trained ophthalmologist.
• Given as an intravitreal injection directly into the eye.
• Performed under sterile hospital or clinic conditions.
• Patients may require regular eye monitoring and follow-up examinations.
• Treatment intervals depend on disease severity and patient response.

Do not self-administer this injection.

Dosage Information

Dosage depends on:

• Type of retinal condition
• Severity of disease
• Response to therapy
• Ophthalmologist recommendation

Typical dosage:

• Intravitreal injection at scheduled intervals as prescribed by the eye specialist.

Regular eye examinations are important during treatment.

Advantages of Pagenax Brolucizumab 120mg/ml Injection

• Helps improve or maintain vision
• Reduces retinal swelling and fluid leakage
• Advanced anti-VEGF treatment
• Longer treatment intervals for some patients
• Effective for retinal vascular diseases
• Helps manage progressive eye conditions

Possible Side Effects

Common side effects may include:

• Eye redness
• Eye pain
• Blurred vision
• Increased eye pressure
• Floaters
• Eye inflammation
• Sensitivity to light

Seek urgent medical attention if severe eye pain, sudden vision changes, or infection symptoms occur.

Storage Conditions

• Store refrigerated between 2°C to 8°C.
• Do not freeze.
• Protect from direct sunlight.
• Keep in original packaging.
• Keep out of reach of children.

Alternative Indian Brands for Brolucizumab Injection

Alternative brands may include:

• Beovu
• BroluCare
• Broliz
• Retizumab

Availability may vary according to prescription regulations and export permissions.

Why Choose GlobMedIndia?

• Trusted exporter of specialty medicines
• Affordable global pricing
• Genuine pharmaceutical products
• Secure cold-chain packaging
• Fast worldwide delivery support
• Reliable customer service
• Professional medicine export solutions

Visit: GlobMedIndia Official Website

Buy Now Pagenax Brolucizumab 120mg/ml Injection online from GlobMedIndia – The Trusted Medicine Exporter for specialty and ophthalmic medicines.